is a medication used to treat hepatitis C. It is a combination of ledipasvir and sofosbuvir. Cure rates are 94% to 99% in people infected with hepatitis C virus (HCV) genotype. Some evidence also supports use in HCV genotype 3 and 4. It is taken daily by mouth for 8–24 weeks.